{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:17:36Z","timestamp":1793215056107,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijcard.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T13:51:37Z","timestamp":1680702697000},"page":"64-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["How common is hypertrophic cardiomyopathy\u2026 really?: Disease prevalence revisited 27\u00a0years after CARDIA"],"prefix":"10.1016","volume":"382","author":[{"given":"Daniele","family":"Massera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark V.","family":"Sherrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Rowin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2023.04.005_bb0005","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review","volume":"79","author":"Maron","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jchf.2018.03.004","article-title":"Global burden of hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2018","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjcard.2022.07.033","article-title":"Personalized treatment strategies effective in hypertrophic cardiomyopathy do not rely on genomics in 2022: a different tale of precision medicine","volume":"183","author":"Maron","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9149(87)80107-8","article-title":"Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening","volume":"59","author":"Hada","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0035","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(99)00039-X","article-title":"Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities","volume":"33","author":"Maron","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2004.03.007","article-title":"Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the strong heart study)","volume":"93","author":"Maron","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0050","first-page":"225","article-title":"Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania","volume":"36","author":"Maro","year":"2006","journal-title":"Trop. Dr."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0055","first-page":"315","article-title":"Prevalence of hypertrophic cardiomyopathy in a large sample of the Spanish working population","volume":"221","author":"Rodriguez-Capitan","year":"2021","journal-title":"Rev. Clin. Esp (Barc)"},{"key":"10.1016\/j.ijcard.2023.04.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012250","article-title":"Prevalence of unexplained left ventricular hypertrophy by cardiac magnetic resonance imaging in MESA","volume":"8","author":"Massera","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0065","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jamacardio.2021.0689","article-title":"Prevalence of hypertrophic cardiomyopathy in the UK biobank population","volume":"6","author":"Lopes","year":"2021","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0070","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jacc.2021.07.017","article-title":"Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy","volume":"78","author":"de Marvao","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0075","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States","volume":"117","author":"Maron","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/CLEP.S139300","article-title":"Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes","volume":"9","author":"Magnusson","year":"2017","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196612","article-title":"Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-an analysis of over 5 million patients","volume":"13","author":"Husser","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2023.04.005_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191214","article-title":"Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records","volume":"13","author":"Pujades-Rodriguez","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2023.04.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227012","article-title":"Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: a nationwide population-based cohort study","volume":"15","author":"Moon","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2023.04.005_bb0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjcard.2021.08.024","article-title":"Clinical diagnosis of hypertrophic cardiomyopathy over time in the United States (a population-based claims analysis)","volume":"159","author":"Butzner","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0105","doi-asserted-by":"crossref","first-page":"18799","DOI":"10.1038\/s41598-022-20042-9","article-title":"Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China","volume":"12","author":"Bai","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajhg.2012.07.017","article-title":"Burden of rare sarcomere gene variants in the Framingham and Jackson heart study cohorts","volume":"91","author":"Bick","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0115","doi-asserted-by":"crossref","first-page":"364ra151","DOI":"10.1126\/scitranslmed.aag2367","article-title":"Aggregate penetrance of genomic variants for actionable disorders in European and African Americans","volume":"8","author":"Natarajan","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0120","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0130","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/0002-9149(90)91429-A","article-title":"Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening","volume":"65","author":"Lewis","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.005_bb0135","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732300520X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732300520X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:00:48Z","timestamp":1759093248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732300520X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":27,"alternative-id":["S016752732300520X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.04.005","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How common is hypertrophic cardiomyopathy\u2026 really?: Disease prevalence revisited 27\u00a0years after CARDIA","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}